Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Rexahn(AMEX:RNN): Inhibiting Human Cancer Cells +13%

|Includes: Rexahn Pharmaceuticals Inc (RNN)

Rexahn Pharmaceuticals, Inc. (Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics
For more information visit  http://www.worldmarketmedia.com/779/section.aspx/2320/post/rexahnamexrnn-inhibiting-human-cancer-cells-13